HUT75338A - Adenosine derivatives, their preparation and use, and pharmaceutical preparations containing them - Google Patents

Adenosine derivatives, their preparation and use, and pharmaceutical preparations containing them Download PDF

Info

Publication number
HUT75338A
HUT75338A HU9603105A HU9603105A HUT75338A HU T75338 A HUT75338 A HU T75338A HU 9603105 A HU9603105 A HU 9603105A HU 9603105 A HU9603105 A HU 9603105A HU T75338 A HUT75338 A HU T75338A
Authority
HU
Hungary
Prior art keywords
formula
alkyl
compounds
adenosine
compound
Prior art date
Application number
HU9603105A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9603105D0 (en
Inventor
John R Fozard
Fulvio Gadient
Prasad K Kapa
Bonnie L K Mangold
Mahavir Prashad
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9409324A external-priority patent/GB9409324D0/en
Priority claimed from GB9416693A external-priority patent/GB9416693D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HU9603105D0 publication Critical patent/HU9603105D0/hu
Publication of HUT75338A publication Critical patent/HUT75338A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HU9603105A 1994-05-10 1995-05-09 Adenosine derivatives, their preparation and use, and pharmaceutical preparations containing them HUT75338A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9409324A GB9409324D0 (en) 1994-05-10 1994-05-10 New organic compounds, their preparation and use
US24991494A 1994-05-26 1994-05-26
GB9416693A GB9416693D0 (en) 1994-08-18 1994-08-18 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
HU9603105D0 HU9603105D0 (en) 1997-01-28
HUT75338A true HUT75338A (en) 1997-05-28

Family

ID=27267177

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603105A HUT75338A (en) 1994-05-10 1995-05-09 Adenosine derivatives, their preparation and use, and pharmaceutical preparations containing them

Country Status (13)

Country Link
EP (1) EP0759925A1 (pt)
JP (1) JPH09512823A (pt)
CN (1) CN1147815A (pt)
AU (1) AU2546195A (pt)
BR (1) BR9507683A (pt)
CA (1) CA2186847A1 (pt)
CZ (1) CZ327896A3 (pt)
FI (1) FI964468A (pt)
HU (1) HUT75338A (pt)
NO (1) NO964735L (pt)
PL (1) PL316985A1 (pt)
SK (1) SK146096A3 (pt)
WO (1) WO1995030683A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
EP2021350B1 (en) 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
CN108822174A (zh) * 2018-08-29 2018-11-16 上海兆维科技发展有限公司 新型核苷修饰物2’-eoe-鸟嘌呤核苷及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (pt) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
EP0759925A1 (en) 1997-03-05
HU9603105D0 (en) 1997-01-28
CZ327896A3 (en) 1997-03-12
CA2186847A1 (en) 1995-11-16
CN1147815A (zh) 1997-04-16
NO964735L (no) 1997-01-10
WO1995030683A1 (en) 1995-11-16
JPH09512823A (ja) 1997-12-22
FI964468A0 (fi) 1996-11-06
AU2546195A (en) 1995-11-29
PL316985A1 (en) 1997-03-03
SK146096A3 (en) 1997-07-09
FI964468A (fi) 1996-11-06
NO964735D0 (no) 1996-11-08
BR9507683A (pt) 1997-09-23

Similar Documents

Publication Publication Date Title
JP3474073B2 (ja) ウリジンまたはシチジンのアシル誘導体を含有する医薬組成物
US8716270B2 (en) Polymorphic and amorphous salt forms of squalamine dilactate
EP0490818B1 (en) 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof
JP2004521062A (ja) 一酸化窒素に関連する障害の処置のための単糖類および二糖類
JP2002521318A (ja) チオアラビノフラノシル化合物の調製及びその使用
HUT75338A (en) Adenosine derivatives, their preparation and use, and pharmaceutical preparations containing them
US7074773B2 (en) Pharmaceutical composition for diabetic neuropathy
HUT74610A (en) Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds, pharmaceutical compositions containing them, process for producing the same and intermediate
JP2001512130A (ja) 合成インスリン模倣物質
JP5849336B2 (ja) アデニル酸シクラーゼの活性調節剤
EP0979650A1 (en) Antiviral agents
GB2385788A (en) Purinergic receptor ligands for use in reducing intraocular pressure
US5039797A (en) 2'-O-(4-benzoyl)benzoyl nucleoside cyclic monophosphate
CN112673014B (zh) 用于治疗心力衰竭的17β-杂环基-洋地黄类化合物
MXPA96005046A (en) Derivatives of adenos
NZ518861A (en) Treatment of heart rhythm distubances with N6-substituted-5'-(N-substituted) carboxamidoadenosines
US5869526A (en) δ-(S-methylisothioureido)-L-norvaline therapeutic for cerebrovascular diseases having nitric oxide synthase inhibiting factor
US20040044016A1 (en) Antiviral agents
CZ413298A3 (cs) 14-Aminosteroidní sloučeniny, obsahující deoxycukr a O-substituovaný cukru, pro použití jako antiarytmika
JP2001064183A (ja) 虚血・再灌流傷害抑制剤
CZ13192A3 (cs) Nové použití 2‘ -O-alkyladenosinových derivátů pro přípravu léčiva vhodného pro léčení neurodegenerativních poruch
JPH03271239A (ja) トリテルペン誘導体
NZ240719A (en) Adenosine-2',3'-carbonates, process for their preparation and use thereof.
MXPA94007369A (en) Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: NOVARTIS AG., CH

DFD9 Temporary protection cancelled due to non-payment of fee